Sesaki H, Wong E F, Siu C H
Banting and Best Department of Medical Research, University of Toronto, Ontario, Canada.
J Cell Biol. 1997 Aug 25;138(4):939-51. doi: 10.1083/jcb.138.4.939.
DdCAD-1 is a 24-kD Ca2+-dependent cell- cell adhesion molecule that is expressed soon after the initiation of development in Dictyostelium cells. DdCAD-1 is present on the cell surface as well as in the cytosol. However, the deduced amino acid sequence of DdCAD-1 lacks a hydrophobic signal peptide or any predicted transmembrane domain, suggesting that it may be presented on the cell surface via a nonclassical transport mechanism. Here we report that DdCAD-1 is transported to the cell surface via contractile vacuoles, which are normally involved in osmoregulation. Immunofluorescence microscopy and subcellular fractionation revealed a preferential association of DdCAD-1 with contractile vacuoles. Proteolytic treatment of isolated contractile vacuoles degraded vacuole-associated calmodulin but not DdCAD-1, demonstrating that DdCAD-1 was present in the lumen. The use of hyperosmotic conditions that suppress contractile vacuole activity led to a dramatic decrease in DdCAD-1 accumulation on the cell surface and the absence of cell cohesiveness. Shifting cells back to a hypotonic condition after hypertonic treatments induced a rapid increase in DdCAD-1-positive contractile vacuoles, followed by the accumulation of DdCAD-1 on the cell membrane. 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole, a specific inhibitor of vacuolar-type H+-ATPase and thus of the activity of contractile vacuoles, also inhibited the accumulation of DdCAD-1 on the cell surface. Furthermore, an in vitro reconstitution system was established, and isolated contractile vacuoles were shown to import soluble DdCAD-1 into their lumen in an ATP-stimulated manner. Taken together, these data provide the first evidence for a nonclassical protein transport mechanism that uses contractile vacuoles to target a soluble cytosolic protein to the cell surface.
DdCAD-1是一种24千道尔顿的钙离子依赖性细胞间粘附分子,在盘基网柄菌细胞发育开始后不久就会表达。DdCAD-1存在于细胞表面以及细胞质中。然而,DdCAD-1推导的氨基酸序列缺乏疏水信号肽或任何预测的跨膜结构域,这表明它可能通过非经典运输机制呈现在细胞表面。在此我们报告,DdCAD-1通过通常参与渗透调节的收缩泡运输到细胞表面。免疫荧光显微镜和亚细胞分级分离显示DdCAD-1与收缩泡有优先关联。对分离的收缩泡进行蛋白水解处理会降解与泡相关的钙调蛋白,但不会降解DdCAD-1,这表明DdCAD-1存在于泡腔内。使用抑制收缩泡活性的高渗条件会导致细胞表面DdCAD-1积累显著减少以及细胞失去黏附性。在高渗处理后将细胞转移回低渗条件会诱导DdCAD-1阳性收缩泡迅速增加,随后DdCAD-1在细胞膜上积累。7-氯-4-硝基苯并-2-恶唑-1,3-二氮唑是液泡型H⁺-ATP酶的特异性抑制剂,从而也是收缩泡活性的抑制剂,它也抑制DdCAD-1在细胞表面的积累。此外,建立了一个体外重组系统,结果显示分离的收缩泡能够以ATP刺激的方式将可溶性DdCAD-1导入其腔中。综上所述,这些数据为一种非经典蛋白质运输机制提供了首个证据,该机制利用收缩泡将可溶性胞质蛋白靶向运输到细胞表面。